论文部分内容阅读
急性心肌梗死(AMI)治疗的首要目标是早期、完全、持续的开通梗死相关动脉(IRA),恢复心肌的组织灌注。急性期的溶栓治疗和介入治疗都可以达到上述目的,并且已经被几十项大规模临床试验所证实。对于已经过了急性期时间窗的AMI患者来说,行择期经皮冠状动脉成形术(PCI)虽然在大多数情况下可以开通已经闭塞的冠脉,但是否可使患者真正受益一直存在着争议。本文结合近年来的文献对择期PCI的疗效和时机选择问题作一综述。
The primary goal of acute myocardial infarction (AMI) therapy is early, complete, and sustained initiation of infarct-related artery (IRA) and restoration of myocardial perfusion. Acute thrombolytic therapy and interventional treatment can achieve these goals, and has been confirmed by dozens of large-scale clinical trials. For patients with AMI who have already passed the acute time window, elective elective percutaneous transluminal coronary angioplasty (PCI), although in most cases it is possible to open an already closed coronary artery, it remains controversial whether patients can actually benefit . This article combines the literature in recent years on elective PCI efficacy and timing issues are reviewed.